NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

ASw,

Too bad nobody listens to baseless fud mud, but thanks for posting your free advice 😶



Do your own research and seek your own reliable sources. Here’s a topic to research: Consider the vast & rapidly growing market for PD1 blockade technology…

Combos with commercialized drugs such as Merck’s pembrolizumab or other checkpoint inhibitors represent a relatively recent development—those studies have reached PII as of 2025. Undoubtedly, more combo trials are coming, potentially funded by NWBO and/or industry partner(s). NWBO’s platforms have been under continuous clinical development for many years, and we have now entered an exciting new era of COMBO research. Another significant development is NWBO’s recent acquisition of commercial licensing of technologies originating from Pittsburgh and developed at Roswell Park!

Examples of Reliable Sources:
☑️ Regulatory Agencies
☑️ U.S. DoD Grant Peer Reviewers
☑️ U.S. NIH Grant Peer Reviewers
☑️ Independently Peer-Reviewed Medical Journals
☑️ UCLA Jonsson Comprehensive Cancer Center
(NCI-Designated Cancer Center)
☑️ University of Pittsburgh Hillman Cancer Center
(NCI-Designated Cancer Center)
☑️ Roswell Park Comprehensive Cancer Institute
(NCI-Designated Cancer Center)

NCI-Designated Cancer Centers

⭐️ NWBO to Acquire Advent BioServices

⭐️ Recent Conference

⭐️ DCVax-L Combo PII UCLA

⭐️ DC Combo PII Roswell Park

10-Q

NICE UK 🇬🇧 DCVax-L

ASM June 29, 2024

Manufacturing Technology

NWBO Acquires Flaskworks

Roswell Park IP Portfolio

AI Fact-Checking